KRAS and non-small cell lung carcinoma: One baseline sample corresponded to the CSF of a NSCLC patient and was positive for the p.L858R in EGFR. The remaining baseline and four follow‐up samples were CSFs from a NSCLC patient, all of them showed the p.G12V mutation in KRAS mutation but significant changes in the allelic fraction were observed (see below).